Literature DB >> 26636434

Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.

Oneida A Arosarena1,2, Raul A Dela Cadena2,3, Michael F Denny4, Evan Bryant5, Eric W Barr3, Ryan Thorpe6, Fayez F Safadi7.   

Abstract

Nearly 50% of patients with oral squamous cell carcinoma (OSCC) die of metastases or locoregional recurrence. Metastasis is mediated by cancer cell adhesion, migration, and invasion. Osteoactivin (OA) overexpression plays a role in metastases in several malignancies. The aims were to determine how integrin interactions modulate OA-induced OSCC cell migration; and to investigate OA effects on cell survival and proliferation. We confirmed OA mRNA and protein overexpression in OSCC cell lines. We assessed OA's interactions with integrins using adhesion inhibition assays, fluorescent immunocytochemistry and co-immunoprecipitation. We investigated OA-mediated activation of mitogen-activated protein kinases (MAPKs) and cell survival. Integrin inhibition effects on OA-mediated cell migration were determined. We assessed effects of OA knock-down on cell migration and proliferation. OA is overexpressed in OSCC cell lines, and serves as a migration-promoting adhesion molecule. OA co-localized with integrin subunits, and co-immunoprecipitated with the subunits. Integrin blocking antibodies, especially those directed against the β1 subunit, inhibited cell adhesion (P = 0.03 for SCC15 cells). Adhesion to OA activated MAPKs in UMSCC14a cells and OA treatment promoted survival of SCC15 cells. Integrin-neutralizing antibodies enhanced cell migration with OA in the extracellular matrix. OA knock-down resulted in decreased proliferation of SCC15 and SCC25 cells, but did not inhibit cell migration. OA in the extracellular matrix promotes OSCC cell adhesion and migration, and may be a novel target in the prevention of HNSCC spread. J. Cell. Physiol. 231: 1761-1770, 2016.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26636434      PMCID: PMC4836998          DOI: 10.1002/jcp.25279

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  62 in total

Review 1.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

2.  DC-HIL is a negative regulator of T lymphocyte activation.

Authors:  Jin-Sung Chung; Kota Sato; Irene I Dougherty; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

3.  microRNAs: small regulators with a big impact on lipid metabolism.

Authors:  Kathryn J Moore
Journal:  J Lipid Res       Date:  2013-03-09       Impact factor: 5.922

4.  Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung.

Authors:  Simon G Talbot; Cherry Estilo; Ellie Maghami; Inderpal S Sarkaria; Duy Khanh Pham; Pornchai O-charoenrat; Nicholas D Socci; Ivan Ngai; Diane Carlson; Ronald Ghossein; Agnes Viale; Bernard J Park; Valerie W Rusch; Bhuvanesh Singh
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

5.  Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck.

Authors:  Matthew A Ginos; Grier P Page; Bryan S Michalowicz; Ketan J Patel; Sonja E Volker; Stefan E Pambuccian; Frank G Ondrey; George L Adams; Patrick M Gaffney
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

6.  CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.

Authors:  Kam Fai Tse; Michael Jeffers; Vincent A Pollack; Denise A McCabe; Melanie L Shadish; Nikolai V Khramtsov; Craig S Hackett; Suresh G Shenoy; Bing Kuang; Ferenc L Boldog; John R MacDougall; Luca Rastelli; John Herrmann; Michael Gallo; Gadi Gazit-Bornstein; Peter D Senter; Damon L Meyer; Henri S Lichenstein; William J LaRochelle
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

7.  High-level β1-integrin expression in a subpopulation of highly tumorigenic oral cancer cells.

Authors:  Hsiang-Chun Lin; Chao-Liang Wu; Yuh-Ling Chen; Jehn-Shyun Huang; Tung-Yiu Wong; Kuo Yuan
Journal:  Clin Oral Investig       Date:  2013-08-25       Impact factor: 3.573

8.  Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells.

Authors:  Shao Chen Liu; Daniel E Bassi; Shi Yu Zhang; Dana Holoran; Claudio J Conti; Andres J P Klein-Szanto
Journal:  Mol Carcinog       Date:  2002-07       Impact factor: 4.784

9.  Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.

Authors:  Dohun Pyeon; Michael A Newton; Paul F Lambert; Johan A den Boon; Srikumar Sengupta; Carmen J Marsit; Craig D Woodworth; Joseph P Connor; Thomas H Haugen; Elaine M Smith; Karl T Kelsey; Lubomir P Turek; Paul Ahlquist
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

10.  Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function.

Authors:  Samir M Abdelmagid; Mary F Barbe; Mario C Rico; Sibel Salihoglu; Israel Arango-Hisijara; Abdul Hafez Selim; Michael G Anderson; Thomas A Owen; Steven N Popoff; Fayez F Safadi
Journal:  Exp Cell Res       Date:  2008-03-10       Impact factor: 3.905

View more
  5 in total

1.  Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer.

Authors:  Vinay K Venishetty; Werner J Geldenhuys; Tori B Terell-Hall; Jessica I G Griffith; Gregory R Sondag; Fayez F Safadi; Paul R Lockman
Journal:  Curr Cancer Drug Targets       Date:  2017       Impact factor: 3.428

2.  Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.

Authors:  Oneida A Arosarena; Eric W Barr; Ryan Thorpe; Hilary Yankey; Joseph T Tarr; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2017-04-25       Impact factor: 6.384

3.  Glycoprotein NMB promotes tumor formation and malignant progression of laryngeal squamous cell carcinoma.

Authors:  Lev Manevich; Yukari Okita; Yasuhito Okano; Takehito Sugasawa; Kunio Kawanishi; Thanasis Poullikkas; Linda T L Dang Cao; Ling Zheng; Masahiro Nakayama; Shin Matsumoto; Keiji Tabuchi; Mitsuyasu Kato
Journal:  Cancer Sci       Date:  2022-05-18       Impact factor: 6.518

4.  GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma-Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis.

Authors:  Yohei Kawasaki; Hitomi Suzuki; Shinsuke Suzuki; Takechiyo Yamada; Maya Suzuki; Ayumi Ito; Haruka Hatakeyama; Masahito Miura; Yasufumi Omori
Journal:  Pathol Oncol Res       Date:  2022-08-19       Impact factor: 2.874

5.  The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis.

Authors:  Yanpan Gao; Wei Ge
Journal:  Cell Death Dis       Date:  2018-01-18       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.